α2A adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 48, 2014, Pages 17296-17301

  Chena, Yunjia ^a   Penga, Yin ^a   Chea, Pulin ^e   Gannona, Mary ^a   Liua, Yin ^a,b   Lib, Ling ^b   Bu, Guojun ^c   Van Groena, Thomas ^a   Jiaod, Kai ^d   Wanga, Qin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adrenergic receptor |; Amyloid |; Processing |; SorLA |; Sorting

Indexed keywords

EID: 84914162459     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409513111     Document Type: Article

References (32)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer' s disease: Progress and problems on the road to therapeutics. Science 297(5580):353-356.
2. Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2(5):a006270.
3. O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34:185-204.
4. Jiang S, et al. (2014) Trafficking regulation of proteins in Alzheimer's disease. Mol Neurodegener 9:6.
5. Small SA, Gandy S (2006) Sorting through the cell biology of Alzheimer's disease: Intracellular pathways to pathogenesis. Neuron 52(1):15-31.
6. Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283(44):29615-29619.
7. Nixon RA (2005) Endosome function and dysfunction in Alzheimer' s disease and other neurodegenerative diseases. Neurobiol Aging 26(3):373-382.
8. Willnow TE, Andersen OM (2013) Sorting receptor SORLA-a trafficking path to avoid Alzheimer disease. J Cell Sci 126(Pt 13):2751-2760.
9. Reitz C (2012) The role of intracellular trafficking and the VPS10d receptors in Alzheimer' s disease. Future Neurol 7(4):423-431.
10. Lane RF, et al. (2012) Vps10 family proteins and the retromer complex in agingrelated neurodegeneration and diabetes. J Neurosci 32(41):14080-14086.
11. Mecozzi VJ, et al. (2014) Pharmacological chaperones stabilize retromer to limit APP processing. Nat Chem Biol 10(6):443-449.
12. Rogaeva E, et al. (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39(2):168-177.
13. Fjorback AW, et al. (2012) Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing. J Neurosci 32(4):1467-1480.
14. Andersen OM, et al. (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 102(38): 13461-13466.
15. Scherzer CR, et al. (2004) Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol 61(8):1200-1205.
16. Grear KE, et al. (2009) Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Mol Neurodegener 4:46.
17. Caglayan S, et al. (2012) Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain. Arch Neurol 69(3):373-379.
18. Pottier C, et al.; PHRC GMAJ Collaborators (2012) High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry 17(9):875-879.
19. Dodson SE, et al. (2008) Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: Evidence for a proximal role in Alzheimer's disease. J Neurosci 28(48):12877-12886.
20. Hein L (2006) Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326(2):541-551.
21. Haglund M, Sjobeck M, Englund E (2006) Locus ceruleus degeneration is ubiquitous in Alzheimer's disease: Possible implications for diagnosis and treatment. Neuropathology 26(6):528-532.
22. Vassar R, et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735-741.
23. Yan R, et al. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402(6761):533-537.
24. Eason MG, Liggett SB (1996) Chimeric mutagenesis of putative G-protein coupling domains of the alpha2A-adrenergic receptor. Localization of two redundant and fully competent gi coupling domains. J Biol Chem 271(22):12826-12832.
25. Doxey JC, Roach AG, Smith CF (1983) Studies on RX 781094: A selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol 78(3):489-505.
26. Grossman F, Potter WZ, Brown EA, Maislin G (1999) A double-blind study comparing idazoxan and bupropion in bipolar depressed patients. J Affect Disord 56(2-3):237-243.
27. Ni Y, et al. (2006) Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med 12(12):1390-1396.
28. Thathiah A, et al. (2009) The orphan G protein-coupled receptor 3 modulates amy-loid- beta peptide generation in neurons. Science 323(5916):946-951.
29. Fitzgerald PJ (2010) Is elevated norepinephrine an etiological factor in some cases of Alzheimer's disease? Curr Alzheimer Res 7(6):506-516.
30. Cottingham C, Wang Q (2012) α2 adrenergic receptor dysregulation in depressive disorders: Implications for the neurobiology of depression and antidepressant therapy. Neurosci Biobehav Rev 36(10):2214-2225.
31. Cottingham C, Chen H, Chen Y, Peng Y, Wang Q. Genetic variations of α(2)-adrenergic receptors illuminate the diversity of receptor functions. Curr Top Membr 2011; 67:161-190.
32. Riekkinen M, Laakso MP, Jäkälä P (1999) Clonidine impairs sustained attention and memory in Alzheimer's disease. Neuroscience 92(3):975-982.